Wednesday, July 3, 2024
HomeTagsDrug discovery

Tag: drug discovery

spot_imgspot_img

AQEMIA Achieves Research Milestone Against Undruggable Target in Immuno-Oncology with Servier

AQEMIA, a leading company in generative-AI-driven drug discovery, announces the achievement of a research milestone in its collaboration with Servier, an international independent pharmaceutical...

Formation Bio secures $372MM Series D funding to grow drug pipeline and continue expanding AI-driven drug development platform

Formation Bio, a tech-driven and AI-native pharma company, announced that it has raised $372MM of Series D financing. The financing was led by a16z...

BenevolentAI and AstraZeneca Collaboration Yields Continued Success as Further Novel Target Progressed Into Portfolio

BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for systemic lupus erythematosus...

Exscientia Appoints John P. Overington as Chief Technology Officer & Maria-Louise Fjällskog as Interim Chief Medical Officer

Exscientia plc announced the appointment of two technology and clinical development leaders to senior roles to significantly strengthen the impact of differentiating technology applications...

DeepCure Turns Complex Drug Designs into Testable Molecules with Robotic Synthesis Breakthrough

Inspired Chemistry™ platform eliminates manual chemical synthesis as a key bottleneck in drug discovery with automated high-throughput, multi-step synthesis to enable more complex and...

Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry

Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced the completion of BioHive-2, Recursion’s new NVIDIA DGX SuperPOD AI supercomputer,...

VantAI Appoints John Cuozzo as Senior Vice President, Head of Drug Discovery

VantAI, a leader in generative AI and drug discovery, announced the appointment of John Cuozzo, PhD as SVP, Head of Drug Discovery. Cuozzo is...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

[tds_leads input_placeholder=”Your email address” btn_horiz_align=”content-horiz-center” pp_msg=”SSd2ZSUyMHJlYWQlMjBhbmQlMjBhY2NlcHQlMjB0aGUlMjAlM0NhJTIwaHJlZiUzRCUyMiUyMyUyMiUzRVByaXZhY3klMjBQb2xpY3klM0MlMkZhJTNFLg==” pp_checkbox=”yes” tdc_css=”eyJhbGwiOnsibWFyZ2luLXRvcCI6IjMwIiwibWFyZ2luLWJvdHRvbSI6IjQwIiwiZGlzcGxheSI6IiJ9LCJwb3J0cmFpdCI6eyJtYXJnaW4tdG9wIjoiMTUiLCJtYXJnaW4tYm90dG9tIjoiMjUiLCJkaXNwbGF5IjoiIn0sInBvcnRyYWl0X21heF93aWR0aCI6MTAxOCwicG9ydHJhaXRfbWluX3dpZHRoIjo3NjgsImxhbmRzY2FwZSI6eyJtYXJnaW4tdG9wIjoiMjAiLCJtYXJnaW4tYm90dG9tIjoiMzAiLCJkaXNwbGF5IjoiIn0sImxhbmRzY2FwZV9tYXhfd2lkdGgiOjExNDAsImxhbmRzY2FwZV9taW5fd2lkdGgiOjEwMTksInBob25lIjp7Im1hcmdpbi10b3AiOiIyMCIsImRpc3BsYXkiOiIifSwicGhvbmVfbWF4X3dpZHRoIjo3Njd9″ display=”column” gap=”eyJhbGwiOiIyMCIsInBvcnRyYWl0IjoiMTAiLCJsYW5kc2NhcGUiOiIxNSJ9″ f_msg_font_family=”downtown-sans-serif-font_global” f_input_font_family=”downtown-sans-serif-font_global” f_btn_font_family=”downtown-sans-serif-font_global” f_pp_font_family=”downtown-serif-font_global” f_pp_font_size=”eyJhbGwiOiIxNSIsInBvcnRyYWl0IjoiMTEifQ==” f_btn_font_weight=”700″ f_btn_font_size=”eyJhbGwiOiIxMyIsInBvcnRyYWl0IjoiMTEifQ==” f_btn_font_transform=”uppercase” btn_text=”Unlock All” btn_bg=”#000000″ btn_padd=”eyJhbGwiOiIxOCIsImxhbmRzY2FwZSI6IjE0IiwicG9ydHJhaXQiOiIxNCJ9″ input_padd=”eyJhbGwiOiIxNSIsImxhbmRzY2FwZSI6IjEyIiwicG9ydHJhaXQiOiIxMCJ9″ pp_check_color_a=”#000000″ f_pp_font_weight=”600″ pp_check_square=”#000000″ msg_composer=”” pp_check_color=”rgba(0,0,0,0.56)” msg_succ_radius=”0″ msg_err_radius=”0″ input_border=”1″ f_unsub_font_family=”downtown-sans-serif-font_global” f_msg_font_size=”eyJhbGwiOiIxMyIsInBvcnRyYWl0IjoiMTIifQ==” f_input_font_size=”eyJhbGwiOiIxNCIsInBvcnRyYWl0IjoiMTIifQ==” f_input_font_weight=”500″ f_msg_font_weight=”500″ f_unsub_font_weight=”500″]

Must read

spot_img